HQL insider trading — abrdn Life Sciences Investors
Over the last 90 days, insiders at abrdn Life Sciences Investors (HQL) made 1 open-market purchase worth $10K and 0 open-market sales worth $0, making them net buyers by $10K. The largest purchase was by Mahai Chris Lavictoire (Director), who bought 527 shares for $10K on Jul 16, 2026.
Updated Oct 16, 2026.
Recent HQL insider transactions
Every Form 4 filed by abrdn Life Sciences Investors officers, directors and 10% owners in the last 90 days, newest first. P = open-market purchase, S = open-market sale; other codes are awards, option exercises, tax withholding or gifts.
| Trade date | Insider | Role | Type | Ownership | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|---|
| Jul 16, 2026 | Mahai Chris Lavictoire | Director | P · Purchase | Direct | 527 | $19.92 | $10K | Form 4 |
HQL insider trading FAQ
Are insiders buying HQL stock?
Yes. In the last 90 days, abrdn Life Sciences Investors insiders made 1 open-market purchase totaling $10K, and no open-market sales. Purchases with the insider's own money are generally seen as a stronger signal than sales, which happen for many reasons (taxes, diversification, planned 10b5-1 sales).
Who are the insiders trading HQL?
Recent buyers: Mahai Chris Lavictoire.
Where does HQL insider trading data come from?
Every transaction comes from SEC Form 4 filings on EDGAR. Company officers, directors and 10% owners must file a Form 4 within two business days of buying or selling. InsiderBolt reads these filings directly from the SEC.
More stocks with insider activity
Insider trading data is for informational purposes only and is not investment advice. Filings can be amended; always confirm details on SEC EDGAR.